Work

Liquid biopsy (LB)-based comprehensive genomic profiling (CGP) of circulating tumor DNA (ctDNA) for the evaluation of patients with myeloid neoplasms.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.e19064

Authors: Douglas A Mata, Mina L. Xu, Vignesh Shanmugam, Hanna Tukachinsky, Alexa Betzig Schrock, Jeffrey S. Ross, Erik Abraham Williams, Meagan Montesion, Brennan J. Decker, Jo-Anne Vergilio, Geoffrey R. Oxnard, Jamal K. Benhamida

Institutions: Foundation Medicine (United States), Yale University, Broad Institute, Brigham and Women's Hospital, Harvard University, Massachusetts Institute of Technology, University of California, San Francisco, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Cancer Genomics and Diagnostics

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Foundation Medicine

OpenAlex ID: W4282019696

Cites:

Cited by: 1

Related to: 10